Methotrexate myelopathy with extensive transverse necrosis: Report of an autopsy case

Neuropathology

Volumn 34, Issue 6, 2014, Pages 547-553

  Shintaku, Masayuki ^a   Toyooka, Nao ^a   Koyama, Takashi ^a   Teraoka, Shunsuke ^a   Tsudo, Mitsuru ^a  

^a OSAKA RED CROSS HOSPITAL   (Japan)

Author keywords

Cytosine arabinoside; Methotrexate; Myelopathy; Pathogenesis; Transverse necrosis

Indexed keywords

CYTARABINE; METHOTREXATE; FOLIC ACID ANTAGONIST;

AGED; ARTICLE; AUTOPSY; BLOOD VESSEL INJURY; BONE MARROW METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; ENDOTHELIAL DYSFUNCTION; FEMALE; FLACCID PARALYSIS; HISTOPATHOLOGY; HUMAN; KIDNEY METASTASIS; NECROSIS; NERVE DEGENERATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAPLEGIA; RARE DISEASE; SPINAL CORD DISEASE; WALDENSTROEM MACROGLOBULINEMIA; CHEMICALLY INDUCED; COMPLICATION; PATHOLOGY;

AGED; FEMALE; FOLIC ACID ANTAGONISTS; HUMANS; METHOTREXATE; NECROSIS; SPINAL CORD DISEASES; WALDENSTROM MACROGLOBULINEMIA;

EID: 84915813253     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/neup.12135     Document Type: Article

References (29)

1. Price RA, Jamieson PA. The central nervous system in childhood leukemia. II. Subacute leukoencephalopathy. Cancer 1975; 35: 306-318.
2. Liu HM, Maurer HS, Vongsvivut S, Conway JJ. Methotrexate encephalopathy. A neuropathologic study. Hum Pathol 1978; 9: 635-648.
3. Perry A, Schmidt RE. Cancer therapy-associated CNS neuropathology: an update and review of the literature. Acta Neuropathol 2006; 111: 197-212.
4. Rubinstein LJ, Herman MM, Long TF, Wilbur JR. Disseminated necrotizing leukoencephalopathy. A complication of treated central nervous system leukemia and lymphoma. Cancer 1975; 35: 291-305.
5. Clark AW, Cohen SR, Nissenblatt MJ, Wilson SK. Paraplegia following intrathecal chemotherapy. Neuropathologic findings and elevation of myelin basic protein. Cancer 1982; 50: 42-47.
6. von der Weid NX, de Crousaz H, Beck D, Deonna T, Miklossy J, Janzer RC. Acute fatal myeloencephalopathy after combined intrathecal chemotherapy in a child with acute lymphoblastic leukemia. Med Pediatr Oncol 1991; 19: 192-198.
7. Honda D, Ochiai J, Ujihira N, Yoshida M, Sobue G. Methotrexate myelopathy. Neurol Med (Tokyo) 2012; 77: 35-42.
8. Matsubayashi J, Tsuchiya K, Matsunaga T, Mukai K. Methotrexate-related leukoencephalopathy without radiation therapy. Distribution of brain lesions and pathological heterogeneity on two autopsy cases. Neuropathology 2009; 29: 105-115.
9. Yokoo H, Nakazato Y, Harigaya Y, Sasaki N, Igeta Y, Itoh H. Massive myelinolytic leukoencephalopathy in a patient medicated with low-dose oral methotrexate for rheumatoid arthritis. An autopsy report. Acta Neuropathol 2007; 114: 425-430.
10. Grisold W, Lutz D, Wolf D. Necrotizing myelopathy associated with acute lymphoblastic leukemia. Acta Neuropathol 1980; 49: 231-235.
11. Bleyer WA, Drake JC, Chabner BA. Neurotoxicity and elevated cerebrospinal-fluid methotrexate concentration in meningeal leukemia. N Engl J Med 1973; 289: 770-773.
12. Suzuki K, Takemura T, Okeda R, Hatakeyama S. Vascular changes of methotrexate-related disseminated necrotizing leukoencephalopathy. Acta Neuropathol 1984; 65: 145-149.
13. Shibutani M, Okeda R, Hori A, Schipper H. Methotrexate-related multifocal axonopathy. Report of an autopsy case. Acta Neuropathol 1989; 79: 333-335.
14. Okeda R. Two autopsy cases of radiation myelopathy. Consideration about the pathogenesis. Adv Neurol Sci (Tokyo) 1971; 15: 619-639.
15. Jellinger K, Sturm KW. Delayed radiation myelopathy in man. Report of twelve necropsy cases. J Neurol Sci 1971; 14: 389-408.
16. Burns RJ, Jones AN, Robertson JS. Pathology of radiation myelopathy. J Neurol Neurosurg Psychiat 1972; 35: 888-898.
17. Hendin B, DeVivo DC, Torack R, Lell ME, Ragab AH, Vietti TJ. Parenchymatous degeneration of the central nervous system in childhood leukemia. Cancer 1974; 33: 468-482.
18. Skullerud K, Halvorsen K. Encephalomyelopathy following intrathecal methotrexate treatment in a child with acute leukemia. Cancer 1978; 42: 1211-1215.
19. Saiki JH, Thompson S, Smith F, Atkinson R. Paraplegia following intrathecal chemotherapy. Cancer 1972; 29: 370-374.
20. Tomonaga M, Takeno Y, Ishii N, Okayama M. Paraplegia following intrathecal methotrexate. Adv Neurol Sci (Tokyo) 1978; 22: 1204-1211.
21. Reznik M. Acute ascending poliomyelomalacia after treatment of acute lymphocytic leukemia. Acta Neuropathol 1979; 45: 153-157.
22. Shibutani M, Okeda R. Experimental study on subacute neurotoxicity of methotrexate in cats. Acta Neuropathol 1989; 78: 291-300.
23. Linnebank M, Pels H, Kleczar N etal. MTX-induced white matter changes are associated with polymorphisms of methionine metabolism. Neurology 2005; 64: 912-913.
24. Pant SS, Asbury AK, Richardson EP Jr. The myelopathy of pernicious anemia. A neuropathological reappraisal. Acta Neurol Scand 1968; 44 (Suppl. 35): 1-36.
25. Linnebank M, Moskau S, Jürgens A etal. Association of genetic variants of methionine metabolism with methotrexate-induced CNS white matter changes in patients with primary CNS lymphoma. Neuro-oncol 2009; 11: 2-8.
26. Ackermann R, Semmler A, Maurer GD etal. Methotrexate-induced myelopathy responsive to substitution of multiple folate metabolites. J Neurooncol 2010; 97: 425-427.
27. Breuer AC, Pitman SW, Dawson DM, Schoene WC. Paraparesis following intrathecal cytosine arabinoside. A case report with neuropathologic findings. Cancer 1977; 40: 2817-2822.
28. Wolf HK, Anthony DC, Fuller GN. Arterial border zone necrosis of the spinal cord. Clin Neuropathol 1990; 9: 60-65.
29. Scheithauer BW, Rubinstein LJ, Herman MM. Leukoencephalopathy in Waldenström's macroglobulinemia. Immunohistochemical and electron microscopic observations. J Neuropathol Exp Neurol 1984; 43: 408-425.